摘要:
Objective:To evaluate the anti-TB treatment-induced renal toxicity of aminoglycoside drugs.Methods:TB patients will be treated in our hospital to be classified according to the type of antibiotics used to elect drug treatment aminoglycoside patients,depending on the drugs used in grouping,Group A (37 cases,capreomycin) group B (41 cases,amikacin),C (34 cases,streptomycin),the small group (39 cases, kanamycin),each group was calculated at different times to clear the rate of serum creatinine,to evaluate groups of renal toxicity. Results:Group A,Group B,Group C,Group D no effective difference in the clearance rate in the pre-treatment (P>0.05);after treatment,the clearance rate of the Group A and Group D decrease greater than Group B and Group C,but the difference inactive (P>0.05);no significant changes in clearance rate within each group at different times,are invalid floating difference (P>0.05).Conclusion: Aminoglycoside drugs in conventional doses used in anti-TB treatment does not cause renal injury,contrast,Chennai for the renal toxicity of m star and streptomycin smaller,safer drugs.%目的:评价在抗结核治疗中应用氨基甙类药物所引起的肾毒性.方法:将在我院接受治疗的结核病患者根据所使用抗生素的种类进行分类,选出治疗用药为氨基甙类的病患,视所用药物分组,分别为甲组(37 例,卷曲霉素)、乙组(41 例,丁胺卡那霉素)、丙组(34 例,链霉素)、丁组(39 例,卡那霉素),计算各组不同时间清除血清肌酐的速率,以评价各组的肾毒性.结果:甲组、乙组、丙组、丁组在治疗前的清除速率无有效差异(P>0.05); 治疗后甲组和丁组的清除速率降低幅度大于乙组和丙组,但差异无效(P>0.05); 各组不同时间内的清除速率无明显变化,浮动差异均无效(P>0.05).结论:氨基甙类药物可在常规剂量下应用于抗结核的治疗中,不会造成肾功能损伤,相较之下,奈替米星和链霉素的肾毒性更小,用药更安全.